Jeil Pharmaceutical Co Ltd (271980) — Working Capital to Net Assets Ratio
Jeil Pharmaceutical Co Ltd (271980) has a Working Capital to Net Assets ratio of 29.2% as of September 2025. Working capital of ₩71.17 Billion (current assets of ₩312.34 Billion minus current liabilities of ₩241.17 Billion) is measured against net assets of ₩243.59 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 271980 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jeil Pharmaceutical Co Ltd Working Capital to Net Assets (2017–2024)
This chart shows how Jeil Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 29.2%, reflecting working capital of ₩71.17 Billion against net assets of ₩243.59 Billion KRW. See Jeil Pharmaceutical Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Jeil Pharmaceutical Co Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jeil Pharmaceutical Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 271980 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 23.4% | ₩51.35 Billion | ₩219.32 Billion | ₩343.04 Billion | ₩291.69 Billion | ▲ +24.1 pp |
| 2023 | -0.7% | ₩-1.12 Billion | ₩157.03 Billion | ₩317.05 Billion | ₩318.17 Billion | ▼ -15.5 pp |
| 2022 | 14.8% | ₩22.98 Billion | ₩155.60 Billion | ₩291.64 Billion | ₩268.66 Billion | ▼ -22.7 pp |
| 2021 | 37.5% | ₩62.73 Billion | ₩167.35 Billion | ₩284.67 Billion | ₩221.94 Billion | ▲ +3.0 pp |
| 2020 | 34.5% | ₩59.45 Billion | ₩172.48 Billion | ₩277.51 Billion | ₩218.06 Billion | ▲ +1.8 pp |
| 2019 | 32.7% | ₩55.61 Billion | ₩170.04 Billion | ₩264.13 Billion | ₩208.52 Billion | ▼ -9.9 pp |
| 2018 | 42.6% | ₩78.80 Billion | ₩184.93 Billion | ₩273.36 Billion | ₩194.56 Billion | ▼ -9.2 pp |
| 2017 | 51.8% | ₩92.15 Billion | ₩177.99 Billion | ₩298.60 Billion | ₩206.46 Billion | — |